1. Home
  2. XP vs RGEN Comparison

XP vs RGEN Comparison

Compare XP & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XP Inc.

XP

XP Inc.

HOLD

Current Price

$17.32

Market Cap

8.8B

Sector

Finance

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$163.11

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XP
RGEN
Founded
2001
1981
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
8.2B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
XP
RGEN
Price
$17.32
$163.11
Analyst Decision
Strong Buy
Buy
Analyst Count
5
11
Target Price
$22.80
$177.18
AVG Volume (30 Days)
4.6M
600.1K
Earning Date
02-17-2026
02-19-2026
Dividend Yield
1.03%
N/A
EPS Growth
18.53
N/A
EPS
1.76
0.03
Revenue
$3,229,174,949.00
$707,890,000.00
Revenue This Year
$17.10
$17.86
Revenue Next Year
$12.69
$12.44
P/E Ratio
$9.87
$5,247.54
Revenue Growth
8.33
11.74
52 Week Low
$10.90
$102.97
52 Week High
$20.64
$182.52

Technical Indicators

Market Signals
Indicator
XP
RGEN
Relative Strength Index (RSI) 52.95 48.28
Support Level $16.84 $158.80
Resistance Level $17.56 $172.51
Average True Range (ATR) 0.47 6.24
MACD 0.14 -0.83
Stochastic Oscillator 85.27 25.84

Price Performance

Historical Comparison
XP
RGEN

About XP XP Inc.

XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: